The effect of microalga Spirulina platensis supplement on the recovery of patients with coronavirus hospitalized in the coronavirus ward and reduction of mortality due to the disease.

Tehran University of Medical Sciences0 个研究点目标入组 240 人开始时间: 待定最近更新: 2023年3月13日

适应症

试验速览

暂无简介。

•Pregnancy or lactation.
•Any history of drug allergy.
•Active, clinically significant chronic illness or human immunodeficiency virus disease.
•Significant organ dysfunctions such as renal failure, liver dysfunction, CHF, or serious and unstable cardiac condition.
•Underlying conditions that can affect patients' ability to provide adequate data.
•Inability or refusal to sign the informed consent.
•Any concurrent diseases or conditions which delay wound healing (cancer, vasculitis, immunosuppressive disorders, etc.)
•Treatment with corticosteroids, Treatment with blood thinners(Warfarin), immunosuppressants, radiotherapy, or chemotherapy.
•Receiving any investigational drug within 30 days prior to screening.
•Abnormal liver enzymes and total bilirubin > 1.5 times of normal upper limit.
•Specific and rare diseases such as people with HIV who are not receiving antiretroviral treatment, multiple sclerosis, SLE, rheumatoid arthritis, and PKU.
•Observation of clinical signs not previously seen in patients with coronavirus and unusual complaints from patients.
•Severe nausea after taking medication that does not improve with routine supportive treatment is considered as an exclusion criterion.

发起方